Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results

Cancer
N J BundredRobert E Coleman

Abstract

Letrozole is safe and effective in postmenopausal women with estrogen receptor-positive early breast cancer, but long-term aromatase inhibitor use may cause bone loss and increase fracture risk. This study evaluated an immediate or delayed strategy of bone protection therapy with zoledronic acid. A total of 1065 patients who were receiving adjuvant letrozole were randomized to immediate-start or delayed-start zoledronic acid (4 mg intravenously biannually for 5 years). The delayed group received zoledronic acid if lumbar spine or total hip T-score decreased below -2.0 or when a nontraumatic fracture occurred. The primary endpoint was change in lumbar spine bone mineral density (BMD) at Month 12. Secondary endpoints included changes in total hip BMD, serum bone turnover markers, and safety at Month 12. Lumbar spine BMD increased from baseline in the immediate arm, while it decreased from baseline in delayed-arm patients. At Month 12, the differences between the groups in lumbar spine and total hip BMD were 5.7% (P < .0001; 95% confidence intervals [CI], 5.2% to 6.1%), and 3.6% (P < .0001; 95% CI, 3.3 to 4.0%), respectively. Both regimens were well tolerated with few serious adverse events. Bone pain was higher in the immediate g...Continue Reading

References

May 23, 2002·Recent Progress in Hormone Research·Evan R Simpson, Mitch Dowsett
Jun 7, 2002·Endocrine Reviews·B Lawrence RiggsL Joseph Melton
Sep 10, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce E HillnerUNKNOWN American Society of Clinical Oncology
Mar 12, 2004·The New England Journal of Medicine·R Charles CoombesUNKNOWN Intergroup Exemestane Study
May 26, 2004·Archives of Internal Medicine·Ethel S SirisMarc L Berger
Jun 9, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Olof JohnellAlan Tenenhouse
Jun 23, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Richard Eastell, Rosemary Hannon
Jun 25, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Jürgen Geisler, Per Eystein Lønning
Jul 28, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Richard EastellUNKNOWN ATAC Trialists' group
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam BrufskyEdith A Perez
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael F X GnantUNKNOWN Austrian Breast and Colorectal Cancer Study Group
May 4, 2007·The New England Journal of Medicine·Dennis M BlackUNKNOWN HORIZON Pivotal Fracture Trial

❮ Previous
Next ❯

Citations

May 4, 2012·Journal of Cancer Research and Clinical Oncology·Christos MarkopoulosHelen Gogas
Apr 12, 2012·International Journal of Clinical Oncology·Hiroji UemuraUNKNOWN Yokohama Bone Metastasis Study Group
Jul 29, 2010·Breast Cancer Research and Treatment·Daniel Prieto-AlhambraXavier Nogues
Mar 22, 2012·Breast Cancer Research and Treatment·Daniel Prieto-AlhambraXavier Nogues
Jul 14, 2012·Breast Cancer Research and Treatment·Jennifer A LigibelNancy L Keating
Mar 5, 2009·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Masakazu ToiWakako Tsuji
Apr 16, 2013·Clinical Oncology : a Journal of the Royal College of Radiologists·M PoonE Chow
Jan 1, 2012·BoneKEy Reports·Jean-Jacques Body
Feb 14, 2009·The New England Journal of Medicine·Michael GnantC Marth
Jun 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P HadjiJ Green
Sep 5, 2009·Current Opinion in Oncology·Matthew C Winter, Robert E Coleman
Nov 26, 2009·Current Opinion in Obstetrics & Gynecology·Richard L Theriault
Feb 13, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Jason M Hollander, Jeffrey I Mechanick
Jul 16, 2008·BMJ : British Medical Journal·Nicholas C Turner, Alison L Jones
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert E ColemanKatherine N Weilbaecher
Nov 6, 2009·Breast Cancer Research : BCR·Georgios KesisisDavid Miles
Feb 16, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gad RennertStephen B Gruber
Dec 15, 2010·Drug Design, Development and Therapy·Ronald C Hamdy
Jan 1, 2010·Drug, Healthcare and Patient Safety·Luca Dalle CarbonareMaria Teresa Valenti
Jan 1, 2009·OncoTargets and Therapy·Michael Gnant
Dec 20, 2008·Drugs·Katherine A Lyseng-Williamson
Jan 25, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R RizzoliUNKNOWN European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO)
Apr 13, 2011·Journal of Cell Communication and Signaling·Osama Hussein, Svetlana V Komarova
Jun 30, 2009·Current Opinion in Supportive and Palliative Care·Robert Coleman, Michael Gnant
Mar 23, 2011·Expert Review of Anticancer Therapy·Sigrun ResslerRichard Greil
Feb 24, 2011·Expert Review of Anticancer Therapy·Gennaro DanieleFrancesco Perrone
Sep 19, 2009·Expert Review of Anticancer Therapy·Sheila A Doggrell
May 14, 2011·Expert Opinion on Drug Metabolism & Toxicology·Antonella De LucaNicola Normanno
Apr 2, 2008·Expert Opinion on Pharmacotherapy·Adam M Brufsky
Apr 10, 2010·Expert Opinion on Emerging Drugs·Francesco BertoldoStefania Boldini
Sep 2, 2008·Expert Opinion on Drug Safety·Sundus Ozair, Shabana Iqbal
Oct 28, 2010·Expert Opinion on Pharmacotherapy·Onder TonyaliKadri Altundag

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved